These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10520975)

  • 41. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
    Abikoff H; McGough J; Vitiello B; McCracken J; Davies M; Walkup J; Riddle M; Oatis M; Greenhill L; Skrobala A; March J; Gammon P; Robinson J; Lazell R; McMahon DJ; Ritz L;
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):418-27. PubMed ID: 15843763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressant treatment outcomes of psychogenic movement disorder.
    Voon V; Lang AE
    J Clin Psychiatry; 2005 Dec; 66(12):1529-34. PubMed ID: 16401153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
    Schmidt ME; Fava M; Robinson JM; Judge R
    J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):151-62. PubMed ID: 18084873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Open-label tiagabine monotherapy for major depressive disorder with anxiety.
    Carpenter LL; Schecter JM; Tyrka AR; Mello AF; Mello MF; Haggarty R; Price LH
    J Clin Psychiatry; 2006 Jan; 67(1):66-71. PubMed ID: 16426090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
    Kornstein SG; Wohlreich MM; Mallinckrodt CH; Watkin JG; Stewart DE
    J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
    Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
    J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study.
    Amsterdam JD; Hooper MB; Amchin J
    J Clin Psychiatry; 1998 May; 59(5):236-40. PubMed ID: 9632034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
    Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF
    J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.